Discontinued — last reported Q4 '25
Interest Paid
McKesson Interest Paid remained flat by 0.0% to $53.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.3%, from $68.25M to $53.00M. Over 4 years (FY 2022 to FY 2026), Interest Paid shows an upward trend with a 3.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
Detailed definition
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Peer comparison
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paidHistorical Data
| FY'22 | FY'23 | FY'24 | FY'25 | FY'26 | |
|---|---|---|---|---|---|
| Value | $186.00M | $224.00M | $234.00M | $273.00M | $212.00M |
| YoY Change | — | +20.4% | +4.5% | +16.7% | -22.3% |
Interest Paid at Other Companies
Frequently Asked Questions
- What is McKesson's interest paid?
- McKesson (MCK) reported interest paid of $53.00M in Q1 2026.
- How has McKesson's interest paid changed year-over-year?
- McKesson's interest paid decreased by 22.3% year-over-year, from $68.25M to $53.00M.
- What is the long-term trend for McKesson's interest paid?
- Over 4 years (2022 to 2026), McKesson's interest paid has grown at a 3.3% compound annual growth rate (CAGR), from $186.00M to $212.00M.
- What does interest paid mean?
- The actual cash paid to lenders for interest on debt.